The Israeli Competition Director General recently announced he had reached an agreement with the British pharmaceutical company Leadiant Biosciences. According to the agreement, Leadiant undertook to pay ILS 110,000 to the...more
For the first time, the Israel Competition Authority has opened enforcement proceedings against a monopolist for abuse of its dominant position by charging an unfairly high price. Subject to a hearing, the authority intends...more
11/29/2021
/ Abuse of Dominance ,
Competition Authorities ,
Drug Pricing ,
Government Investigations ,
Israel ,
Monopolization ,
Netherlands ,
Personal Liability ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Gouging